Navigation Links
New Interim Analysis From Observational Study Suggests That Delivery Of Insulin Via Valeritas' V-Go Shows Promise In Improving Glycemic Control For Patients With Type 2 Diabetes
Date:5/2/2013

BRIDGEWATER, N.J., May 2, 2013 /PRNewswire/ -- Valeritas, makers of the V-Go® insulin delivery device, announced new interim analysis from an observational study today that suggest patients with Type 2 diabetes who switched to the V-Go insulin delivery device from their previous baseline treatment experienced potentially significant improved glycemic control and a reduction in total daily insulin dose. The interim results, part of a planned interim analysis performed as part of a long-term, prospective, observational study, were presented at the American Association of Clinical Endocrinologists (AACE) 22nd annual scientific and clinical congress.1

V-Go is a simple, fully-disposable device that delivers a continuous basal rate of insulin for 24 hours with on-demand mealtime dosing. It is designed to be easier to use and assist with blood glucose control in adult patients who require insulin.

"This observational study enables us to obtain data about the actual clinical benefit of the V-Go when used as directed by practicing physicians in a real-world setting," said Dr. Cheryl Rosenfeld , primary study investigator affiliated with North Jersey Endocrine Consultants. "These interim results are very promising, suggesting improved glycemic control, a reduction in total daily insulin dose with a nominal change in weight in patients switching to the V-Go."

The SIMPLE study, "Effectiveness of V-Go for Patients with Diabetes in a Real-world Setting: A Long-term, Prospective, Observational Registry," compared the changes in baseline and endpoint A1C measures and observed glycemic control, insulin dose requirements and other parameters. Patients with Type 2 diabetes and a baseline A1C greater than 7 percent were enrolled. Study participants were then switched from one of five baseline treatments to the V-Go for their basal and mealtime insulin delivery.'/>"/>

SOURCE Valeritas, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Interim results of VITOBA™ (VImpaT® added to One Baseline AED) Study Presented at the 64th Annual Meeting of the American Academy of Neurology
2. Interim Results Reported for Phase I Open-Label Clinical Trial for the Treatment of PTSD and MDD Using External Trigeminal Nerve Stimulation (eTNS™) - The USB Port to the Brain™
3. Inspiration Biopharmaceuticals Reports Positive Interim Results from the Accur8 Phase 2/3 Study of OBI-1 in Acquired Hemophilia A at WFH 2012 World Congress
4. Psyadon Announces Positive Interim Analysis of Phase 2 Study of Ecopipam for the Treatment of Tourette Syndrome
5. IRIDEX Appoints Chairman William M. Moore as Interim President & CEO
6. Sihuan Pharmaceutical Announces 2012 Interim Results
7. Medical Marijuana Inc. Announces Ted Caligiuri as Interim President and CEO
8. XBiotech Reports Positive Phase II Interim Analysis Results From Type 2 Diabetes Study
9. OncoSec Medical Reports Positive Interim Efficacy Results from Phase IV Study of NeoPulse in Skin Cancer Patients
10. DelMar Pharmaceuticals to Present Interim Clinical Data on VAL-083 in Refractory Glioblastoma at Society for Neuro-Oncology (SNO) Annual Meeting
11. XBiotech Reports Positive Phase II Interim Analysis Results in Vascular Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... Mich. , Aug. 22, 2014  Diplomat, ... selected as one of two winners in the ... Specialty Pharmacy Solutions, LLC. The results of the ... of Specialty Pharmacy News. Diplomat ... Diplomat University Education & Training program. Through Diplomat ...
(Date:8/22/2014)... /CNW/ - On Aug. 20, at its annual meeting ... Association (CMA) voted on and approved a delegate resolution ... cannabis. Bedrocan Cannabis Corp., a leading Canadian licensed producer ... The CMA is quite right to point ... any plant material, including medicinal cannabis. While some patients, ...
(Date:8/22/2014)... , Aug. 22, 2014  Dr. Mark Rasak ... the Diamond Lifetime Achievement Award in the field of ... of Cardiovascular Clinical Associates. Dr. Rasak has ... all major aspects of the business; overseeing the daily ... primary coronary intervention. In addition, he is an honored ...
Breaking Medicine Technology:Diplomat honored as a Top Innovator by Specialty Pharmacy News 2Bedrocan Canada Statement Regarding Canadian Medical Association Motion on Smoking Marijuana 2Dr. Mark Rasak, MD is recognized by Continental Who's Who with the Diamond Lifetime Achievement Award 2
(Date:8/22/2014)... San Jose, CA (PRWEB) August 22, 2014 ... are now offering a new teeth whitening technique. Air ... during regular cleaning appointments. , Dark teeth can be ... into two categories: external stains and internal stains. External ... Internal stains can be caused by certain medications, such ...
(Date:8/22/2014)... found that targeted automated alerts in electronic health ... patients with urinary catheters. In addition, when the ... of improvement dramatically increased. , The alerts help ... in the first place and then alert them ... not been removed within a recommended time period. ...
(Date:8/22/2014)... August 22, 2014 Natural Clear Vision ... to restore his own vision from legally blind to perfect ... an investigative review. , “There is a huge portion ... for everyday function, and most people just think that’s the ... eye surgery that can be pretty risky at times,” reports ...
(Date:8/22/2014)... found in the circulating free tumor DNA (ctDNA) from ... patients correlates well with the EGFR mutations from patient-matched ... therapy is approved for EGFR activating mutation positive patients ... status is with DNA derived directly from tumor tissue, ... abundant and less invasive source of tumor DNA may ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 Testosterone ... filed in U.S. courts on behalf of men ... their use of prescription low testosterone therapies, Bernstein ... new claim was filed against Pfizer Inc. on ... suffered life-threatening heart issues due to his use ...
Breaking Medicine News(10 mins):Health News:Japantown Dental Introduces Air Polishing 2Health News:Penn study: Electronic alerts significantly reduce catheter-associated urinary tract infections 2Health News:Penn study: Electronic alerts significantly reduce catheter-associated urinary tract infections 3Health News:Natural Clear Vision: Review Exposes Kevin Richardson’s Program for Restoring Vision Naturally 2Health News:High concordance between EGFR mutations from circulating-free tumor DNA and tumor tissue in non-small cell lung cancer 2Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 2Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 3Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 4
... than those that are not. A new study says ... as celiac disease”// ,CD, also known as celiac ... to result from the activation of both a cell-mediated ... glutens (prolamins and glutenins) found in wheat, barley, rye, ...
... Chemistry and Industry magazine says that tropical plants imported ... dengue and other related illnesses. // ,The Asian ... and this species was detected in the Netherlands leading ... These mosquitoes were detected in imported bamboo in a ...
... dengue fever vaccine full of promise is being tried in ... the GlaxoSmithKline vaccine //have been completed in the US and ... finished by the end of next year, Dr. Hans L. ... interest in making the vaccine available fast, given that this ...
... with anti-TNF agents (etanercept) and chemotherapy drug methotrexate ... treatment of Rheumatoid Arthritis.// Furthermore, the progression of ... over three quarters of patients. The chronic nature ... for prevention of long-term joint damage in addition ...
... Aurobindo Pharma Ltd has announced that U.S. Food ... capsules USP 250 mg & 500 mg.// ... of bacterial infections such as bronchitis, tonsillitis, ear ... has achieved another major milestone by obtaining the ...
... conducted on nearly 50 nursery school children has revealed ... it on to their children as well, //resulting in ... were considerably higher amongst the group of children studied. ... children were greater than twice the normal levels in ...
Cached Medicine News:Health News:Breastfeeding: A Boon For Cealiac Disease 2Health News:Combination Therapy With ENBREL And Methotrexate Found Effective In RA Treatment 2Health News:Children’s Stress Levels Directly Related To Maternal Job Satisfaction 2
... Slit Lamp features easy-to-use controls to help ... to a halogen bulb that gives up ... with powers of 10X and 16X, the ... accepts commercially available C-mount cameras, allowing physicians ...
... uses state-of-the-art waveform analysis and ... a 65MHz rate to obtain ... and averages nine measurements and ... fits comfortably into the hand ...
Perfect for loading small volume samples onto agarose and polyacrylamide gels....
1000 L, Bulk Recommended for 500 and 1000 L pipettes...
Medicine Products: